ATM and metastatic neoplasm: Discrepancy in available evidences might be related to the different prognostic role of ATM loss of function according to disease stage, similarly to what reported for MSI22, and the confounding effects derived from the heterogeneity of available regimens and treatment sequences used for metastatic disease.